Category: Biomarkers
Global Biomarkers
-
Global Liquid Biopsy Market By Offering (Testing Services, Kits, Platform, Other consumables), By Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Others), By Workflow (Sample Preparation, Library Preparation, Sequencing, Data Analysis & Management), By Sample (Blood, Urine, Saliva, Others), By Circulating Biomarkers (Circulating Tumor Cells (CTCs), Cell-free Nucleic Acids, Exosomes & Extracellular Vesicles), By Application (Oncological and Non-oncological), By End User (Clinical Laboratories, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies), By Region Competition Forecast & Opportunities, 2027
... Sample (Blood, Urine, Saliva, Others), By Circulating Biomarkers (Circulating Tumor Cells (CTCs), Cell-free Nucleic Acids, Exosomes & Extracellular Vesicles), By Application (Oncological and Non-oncological), By End User (Clinical Laboratories, Academic & Research Institutes, Pharmaceutical & ... Read More
-
Global Multiplexed Diagnostics Market - 2022-2029
... XX % during the forecast period (2022-2029). Biological samples are analyzed using multiplexed diagnostics, which can finish a screening procedure in a single pass. Multiplexed diagnostic assays identify and classify various illnesses and infections, including ... Read More
-
Global Genomic Biomarker Market - 2022-2029
... during the forecast period (2022-2029). Genomic biomarkers are signs that assess for clinical diagnosis based on gene expression, gene mutation, gene regulation, and other gene features. Neurological, oncological, and cardiovascular illnesses can all be detected ... Read More
-
Cancer Biomarkers Market (Type: Protein, Genetics, and Others; and Type of Cancer: Lung, Breast, Leukemia, Melanoma, Colorectal, Prostate, Ovarian, Liver, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... Market – Scope of Report TMR’s report on the global cancer biomarkers market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market ... Read More
-
2022-2026 Global Cancer Diagnostics Market in the USA, Europe, Japan - Sales and Market Shares for Reagent and Instrument Suppliers, Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... LeadingMarketResearch.com provides information and analysis not available from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of ... Read More
-
Global Cancer Biomarkers Market Opportunity Analysis and Industry Forecast till 2031: By Biomarker Type (Protein Biomarker, Genetic Biomarker, Others), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Others), By Profiling Technologies (Omics Technology, Imaging Technologies, Immunoassays, Bioinformatics, Cytogenetics), By Application (Diagnostics, Research & Development, Prognostics, Risk Assessments, Others); and By Region
... (Omics Technology, Imaging Technologies, Immunoassays, Bioinformatics, Cytogenetics), By Application (Diagnostics, Research & Development, Prognostics, Risk Assessments, Others); and By Region The global cancer biomarkers market size was USD 13.4 billion in 2021 and it is ... Read More
-
PD-1/PDL-1 Inhibitor Market - A Global and Regional Analysis: Focus on Epidemiology, Product, and Region - Analysis and Forecast, 2022-2032
... 1 (PD-L1) inhibitor are therapeutic agents that inhibit binding together of these checkpoint proteins on immune cells, eventually preventing tumors to escape the host immune defense mechanism and control the disease progression. The first PD-1 ... Read More
-
Global and China In Vivo Imaging Systems Market Status and Forecast 2022-2028
... and is forecast to a readjusted size of US$ 139.56 million by 2028 with a CAGR of 3.11% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Optical Imaging accounting ... Read More
-
Global Central Nervous System (CNS) Biomarkers Market Research Report 2021-2032
... industry, and CAGR in order to provide a comprehensive outlook of the global market. Additionally, the report also highlights the challenges impeding market growth and expansion strategies employed by leading companies in the “Central Nervous ... Read More
-
Glycomic Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Class (Isolated and Synthetic), Structures [Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (GPI)-Anchored Proteins & Heparin Based Glycans, Targeting Glycosphingolipids, and Others], Indications (Thrombosis & Chemoprophylaxis, Anaemia, Anti-Adhesive & Anti-Inflammatory, Cataracts, Gaucher’s Disease, MPS-1 & IV, Cancer, Alzheimer’s Disease, Influenza Type A & B, and Others), and Mode of Action [Inhibits Neuraminidase; Inhibits Heparanase and Selectins and Blocks Interactions Between Growth Factors and Heparan Sulfate; Erythropoietin & Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 & 3; Beta & Gamma Interferons; and Others]
... Others], Indications (Thrombosis & Chemoprophylaxis, Anaemia, Anti-Adhesive & Anti-Inflammatory, Cataracts, Gaucher’s Disease, MPS-1 & IV, Cancer, Alzheimer’s Disease, Influenza Type A & B, and Others), and Mode of Action [Inhibits Neuraminidase; Inhibits Heparanase and Selectins ... Read More
-
Clinical Biomarkers - A Global and Regional Analysis: Focus on Offering, Clinical Area, Technology, Application, End User, and Region - Analysis and Forecast, 2022-2032
... biomarkers market was valued at $21,304.3 million, and it is expected to reach $54,294.0 million by 2032, growing at a CAGR of 8.73% during the forecast period 2022-2032. The growth in the global clinical biomarkers ... Read More
-
Global Veterinary Biomarkers Market Size, Share & Industry Trends Analysis Report By Animal Type, By Disease Type, By Product Type (Biomarkers, Kits & Reagents and Biomarker Readers), By Application, By Regional Outlook and Forecast, 2022 - 2028
... - 2028 The Global Veterinary Biomarkers Market size is expected to reach $1.5 billion by 2028, rising at a market growth of 11.7% CAGR during the forecast period. Biomarkers are sensors of biological processes and ... Read More
-
Global Liquid Biopsy Market, By Sampling Type (Blood Sampling, Urine Sampling, Saliva Sampling, and Other Tissue Fluids Sampling), By Product and Service (Assay Kits, Instruments, and Services), By Circulating Biomarker (Circulating Tumor Cells, Circulating Tumor DNA), By Clinical Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring), By Application (Cancer Applications, Non-Cancer Applications), By End User (Reference Laboratories, Hospitals, Physician Laboratories, Academic Researchers, and Others), By Region (North America, Europe, The Asia Pacific, Latin America, and The Middle East and Africa)Trend Analysis, Competitive Market Share & Forecast, 2018-2028
... DNA), By Clinical Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring), By Application (Cancer Applications, Non-Cancer Applications), By End User (Reference Laboratories, Hospitals, Physician Laboratories, Academic Researchers, and Others), By Region (North America, ... Read More
-
2022-2026 Global Tumor Markers Diagnostic Testing Market Assessment: Business Opportunities - USA, Europe, Japan - Oncogenes, Biomarkers, GFs, CSFs, Hormones, Stains, Lymphokines - Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Instrumentation Pipeline, Emerging Opportunities for Suppliers LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends in the ... Read More
-
Bioanalytical Testing Services Market (Product Type: Cell-based Assays, Virology Testing, Serology, Immunogenicity & Neutralizing Antibodies, Toxicology Services, Biomarker Testing, and Pharmacokinetic Testing) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... Services Market – Scope of Report TMR’s report on the global bioanalytical testing services market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of ... Read More
-
Global Cardiac Biomarkers Market 2022-2028
... importance to institute therapy at the earliest and possibly reverse the myocardial damage. Cardiac biomarkers are also a powerful tool for triaging. The global cardiac biomarkers market is expected to increase by USD 7 billion, ... Read More
-
Global IVD Antibodies Market Size study, By Product Type (Cardiac Markers, Tumor Markers, Kidney Injury Markers, Infection and Inflammation Antibodies), By Application (Immunology, Cancer, Cardiovascular Diseases), By End User (Hospitals, Diagnostic Laboratories, Homecare Settings, Others), and Regional Forecasts 2022-2028
... and Regional Forecasts 2022-2028 Global IVD Antibodies Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period ... Read More
-
2022 Global Forecast for Central Nervous System Biomarkers Market (2023-2028 Outlook)-High Tech & Emerging Markets Report
... 50 countries. The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material ... Read More
-
Mice Model Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Inbred Mice, Outbred Mice, Genetically Engineered Mice, Hybrid Mice, Surgically Modified Mice, and Spontaneous Mutant Mice), Service (Breeding, Cryopreservation, Model-in Licensing, Genetic Testing, Quarantine, and Others), Technology (CRISPR, Microinjection, Embryonic Stem cell Injection, Nuclear Transfer, and Others), Indication [Oncology Studies, Immunology & Inflammation Studies, Endocrine Metabolic Studies, Cardiovascular Studies, Central Nervous System (CNS) Studies, Genetic Studies, Infectious Disease Studies, Fibrosis, and Other Disease Studies], End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Others), Application (Preclinical Drug Development, Biomarker Analysis, and Basic Cancer Research), and Mode (In-House and Outsourced)
... Genetic Testing, Quarantine, and Others), Technology (CRISPR, Microinjection, Embryonic Stem cell Injection, Nuclear Transfer, and Others), Indication [Oncology Studies, Immunology & Inflammation Studies, Endocrine Metabolic Studies, Cardiovascular Studies, Central Nervous System (CNS) Studies, Genetic Studies, ... Read More
-
Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End Users, Clinical Application, Cancer Types, Sample Type, Regional & Country Wise Analysis), Impact of COVID-19, Initiatives, Funding, Major Deals, Company Profiles and Recent Developments - Global Forecast to 2030
... Forecast to 2030 The global liquid biopsy market is predicted to surpass US$ 11 Billion by 2030. The advantages of liquid biopsy over solid tumor biopsy, rising prevalence of cancer, increasing preference for non-invasive procedures, ... Read More
-
MRD Testing Market - A Global and Country Analysis: Focus on Technology, Application, End User, Region - Analysis and Forecast, 2022-2027
... projected to reach $2,611.2 million by 2027 from $1,089.3 million in 2021, at a CAGR of 14.53%. The market is driven by certain factors, such as the rising incidence of hematologic malignancies, increasing consumer awareness ... Read More
-
2022-2026 World Cancer Diagnostics Market Database for 90 Countries - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
... and analysis not available from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or ... Read More
-
2022-2026 Global Cancer Diagnostics Market Database for the USA, Europe, Japan - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
... information and analysis not available from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing ... Read More
-
Bioanalytical Testing Services Market by Type, Application (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User and Region (North America, Europe, APAC, Latin America, MEA) - Global Forecast to 2027
... for the detailed examination of biological and biotechnology products. Bioanalysis enables the quantitative measurement of drugs and their metabolites, biological molecules in unnatural locations or concentrations, DNA, and large molecules. The global bioanalytical testing services ... Read More
-
Liquid Biopsy Market - A Global and Regional Analysis: Focus on Offering, Usage, Workflow, Circulating Biomarker, Sample, Technology, Clinical Application, End User, and Region - Analysis and Forecast, 2022-2032
... The global liquid biopsy market was estimated to be at $2,508.2 million in 2021, which is expected to grow with a CAGR of 19.83% and reach $19,066.0 million by 2032. The growth in the global ... Read More
Research Assistance
